Details of Drug-Metabolizing Enzyme (DME)
General Information of Drug-Metabolizing Enzyme (DME) (ID: DECV2ME)
| DME Name | Cytochrome P450 105D7 (cyp105) | ||||
|---|---|---|---|---|---|
| Synonyms | Cytochrome P450 family 105 subfamily D member 7; Pentalenic acid synthase; SAV_7469; cyp105d7; cyp28 | ||||
| Gene Name | cyp28 | ||||
| UniProt ID | |||||
| INTEDE ID | |||||
| 3D Structure | |||||
| EC Number | EC: 1.14.15.11 | ||||
| Lineage | Species: Streptomyces avermitilis | ||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Sequence |
MTEPGTSVSAPVAFPQDRTCPYDPPTAYDPLREGRPLSRVSLYDGRSVWVVTGHAAARAL
LSDQRLSSDRTLPRFPATTERFEAVRTRRVALLGVDDPEHRTQRRMLVPSFTLKRAAALR PRIQETVDGLLDAMEAQGPPAELVSAFALPLPSMVICALLGVPYADHDFFESQSRRLLRG PGIAEVQDARAQLDDYLYALIDRKRKEPGDGLLDDLIQEQLNRGTVDRAELVSLATLLLI AGHETTANMISLGTFTLLRHPEQLAELRAEPGLMPAAVEELLRFLSIADGLLRVATEDIE VAGTTIRADEGVVFATSVINRDAAGFAEPDALDWHRSARHHVAFGFGIHQCLGQNLARAE MEIALGTLFERLPGLRLAAPADEIPFKPGDTIQGMLELPVTW |
||||
| Function | This enzyme is a P-450 heme-thiolate protein, and it catalyzes the conversion of 1-deoxypentalenic acid to pentalenic acid in the biosynthesis of neopentalenolactone antibiotic. | ||||
| KEGG Pathway | |||||
Molecular Interaction Atlas (MIA) of This DME
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 Approved Drug(s) Metabolized by This DME
|
|||||||||||||||||||||||||||||||
|
1 Clinical Trial Drug(s) Metabolized by This DME
|
|||||||||||||||||||||||||||||||
|
1 Discontinued Drug(s) Metabolized by This DME
|
|||||||||||||||||||||||||||||||
|
1 Investigative Drug(s) Metabolized by This DME
|
|||||||||||||||||||||||||||||||
| Experimental Enzyme Kinetic Data of Drugs |
|
||||||||||||||||||||||||||||||
References
